시장보고서

상품코드

1741221

세계의 다사티닙(Dasatinib) 의약품 시장 : 유형별, 적응증별, 유통 채널별, 지역별

Dasatinib Drugs Market, By Type, By Indication, By Distribution Channel, By Geography

발행일: 2025년 03월 | 리서치사:

Coherent Market Insights | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

다사티닙 의약품 시장은 2025년에 16억 4,610만 달러로 평가되었고, 2032년에는 24억 7,510만 달러에 이를 것으로 예측되며, 2025년부터 2032년에 걸쳐 CAGR 6%로 성장할 전망입니다.

보고 범위		보고서 세부 정보
기준 연도	2024년	2025년 시장 규모	16억 4,610만 달러
실적 데이터	2020-2024년	예측 기간	2025-2032년
CAGR(2025-2032년)	6.00%	2032년 가치 예측	24억 7,510만 달러

다사티닙은 특정 유형의 암 치료에 혁신을 가져온 잠재적인 티로신 키나제 억제제입니다. 처음에는 만성 골수성 백혈병(CML)과 필라델피아 염색체 양성 급성 림프구성 백혈병(Ph+ ALL)을 대상으로 한 표적 치료제로 개발된 다사티닙은 BCR-ABL 단백질을 특이적으로 표적화하고 억제하여 암 세포의 성장과 증식을 억제합니다. 뛰어난 효능을 보여, 다사티닙은 이러한 악성 종양 환자의 치료 결과와 생존율을 크게 개선했습니다. 또한 다사티닙은 SRC 가족 키나제 등 다른 티로신 키나제에 대한 억제 효과를 나타내며, 다양한 종양에 대한 적용 가능성을 넓히고 있습니다. 다사티닙은 유망한 치료 옵션이지만 부작용이 동반되므로 주의 깊은 모니터링과 관리가 필요합니다. 현재 진행 중인 연구와 임상 시험은 다사티닙의 복합 요법 가능성을 탐구하며, 암 치료 전략의 추가적인 발전을 위한 길을 열고 있습니다.

시장 역학 :

암의 유병률 증가, 우수한 임상 결과, 승인된 적응증의 확대는 예측 기간 동안 세계의 다사티닙 의약품 시장의 성장을 촉진할 것으로 예상됩니다. 또한 표적 치료제의 개발도 예측 기간 동안 세계의 다사티닙 의약품 시장의 성장을 촉진할 것으로 예상됩니다. 신흥 시장 진출, 복합 요법, 소아 적응증, 제네릭 제품 개발은 예측 기간 동안 세계의 다사티닙 의약품 시장 성장에 성장 기회를 창출할 것으로 예상됩니다.

그러나 치료 비용의 고비용, 엄격한 규제 요건, 잠재적 부작용, 내성 발달은 예측 기간 동안 다사티닙 의약품 시장 성장을 방해할 것으로 예상됩니다.

본 조사의 주요 특징

본 보고서에서는 세계의 다사티닙 의약품 시장을 상세하게 분석했으며, 2024년을 기준 연도으로 한 예측 기간 2025-2032년 시장 규모 및 CAGR을 제공합니다.
또, 다양한 부문에 걸친 잠재적인 수익 기회를 밝혀, 이 시장의 매력적인 투자 제안 매트릭스를 해설했습니다.
또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 발매 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택하는 경쟁 전략 등에 관한 주요 고찰도 제공합니다.
기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 업적, 전략 등의 파라미터에 근거해, 세계의 다사티닙 의약품 시장에 있어서의 주요 기업 프로파일을 제공합니다.
본 보고서의 통찰에 의해 마케팅 담당자나 기업의 경영진은 장래의 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전술에 관한 정보에 근거한 의사 결정을 실시할 수 있습니다.
세계의 다사티닙 의약품 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해 관계자에 대응하고 있습니다.
이해관계자는 세계의 다사티닙 의약품 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정이 용이해집니다.

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 1,646.1 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	6.00%	2032 Value Projection:	USD 2,475.1 Mn

Dasatinib is a potential tyrosine kinase inhibitor that has revolutionized the treatment landscape for certain types of cancer. Initially developed as a targeted therapy for chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), dasatinib specifically targets and inhibits the BCR-ABL protein, suppressing the growth and proliferation of cancer cells. With remarkable efficacy, dasatinib has significantly improved outcomes and increased survival rates in patients with these malignancies. Moreover, dasatinib exhibits inhibitory effects on other tyrosine kinases, including SRC family kinases, broadening its potential application to various tumors. While dasatinib offers a promising therapeutic option, it is not without side effects, necessitating careful monitoring and management. Ongoing research and clinical trials are exploring the potential of dasatinib in combination therapies, paving the way for further advancements in cancer treatment strategies.

Market Dynamics:

The increasing prevalence of cancer, favorable clinical outcomes, and expansion of approved indications are anticipated to drive the growth of the global dasatinib drugs market over the forecast period. Moreover, the development of targeted therapies is also expected to boost the growth of the global dasatinib drugs market over the forecast period. Expansion into emerging markets, combination therapies, pediatric indications, and the development of generic versions are expected to create growth opportunities for the global dasatinib drugs market growth during the forecast period.

However, the high cost of treatment, stringent regulatory requirements, potential adverse effects, the development of resistance are expected to hamper the growth of the dasatinib drugs market over the forecast period.

Key features of the study:

This report provides an in-depth analysis of the global dasatinib drugs market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global dasatinib drugs market based on the following parameters - company highlights, product portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Bristol-Myers Squibb Company, MSN Labs, Lupin, Dr. Reddy's Laboratories, Gilead Sciences, Inc., Hetero Labs, MANUS AKTTEVA BIOPHARMA LLP, Alembic Pharma, JINLAN Pharm-Drugs Technology Co., Ltd., and Zhejiang Hisun Pharma
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global dasatinib drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global dasatinib drugs market

Detailed Segmentation:

Dasatinib Drugs Market, By Type:
- 20 mg
- 50 mg
- 70 mg
Dasatinib Drugs Market, By Indication:
- Chronic Myeloid Leukemia
- Acute Lymphoblastic Leukemia
- Others
Dasatinib Drugs Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Dasatinib drugs market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles:
- Bristol-Myers Squibb
- MSN Labs
- Lupin
- Dr. Reddy's Laboratories
- Hetero Labs
- MANUS AKTTEVA BIOPHARMA LLP
- Alembic Pharma
- JINLAN Pharm-Drugs Technology Co., Ltd.
- Reddy's Laboratories
- Zhejiang Hisun Pharma

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Type
- Market Snippet, By Indication
- Market Snippet, By Distribution channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Increasing prevalence of cancer
- Restraints
Increasing product recall
- Opportunities
Expansion into emerging markets
Combination therapies
Pediatric indications
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Dasatinib Drugs Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Dasatinib Drugs Market, By Type, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
20 mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
50 mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
70 mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

6. Dasatinib Drugs Market, By Indication, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Chronic Myeloid Leukemia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Acute Lymphoblastic Leukemia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

7. Dasatinib Drugs Market, By Distribution Channel, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Mn)

8. Dasatinib Drugs Market, By Region, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
  - U.S.
  - Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Mn)
  - North Africa
  - South Africa
  - Central Africa

9. Competitive Landscape

Bristol-Myers Squibb
- Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- MSN Labs
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Hetero Labs
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Alembic Pharma,
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- JINLAN Pharm-Drugs Technology Co., Ltd.,
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Reddy's,
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Zhejiang Hisun Pharma
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Analyst Views

10. Section

Research Methodology
About us

세계의 다사티닙(Dasatinib) 의약품 시장 : 유형별, 적응증별, 유통 채널별, 지역별

Dasatinib Drugs Market, By Type, By Indication, By Distribution Channel, By Geography

시장 역학 :

본 조사의 주요 특징

목차

제1장 조사의 목적과 전제조건

제2장 시장 전망

제3장 시장 역학, 규제, 동향 분석

제4장 코로나바이러스(COVID-19) 팬데믹의 영향

제5장 다사티닙 의약품 시장 : 유형별(2020-2032년)

제6장 다사티닙 의약품 시장 : 적응증별(2020-2032년)

제7장 다사티닙 의약품 시장 : 유통 채널별(2020-2032년)

제8장 다사티닙 의약품 시장 : 지역별(2020-2032년)

제9장 경쟁 구도

제10장 섹션